Drug interactions
Hydroxyurea + Idecabtagene vicleucel
Severity: Major
Hydroxyurea and Idecabtagene vicleucel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Hydroxyurea is myelosuppressive and may impair T-cell collection and CAR-T expansion. It may also add to infection risk after infusion.
What this interaction means in plain words
Hydroxyurea and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Hydroxyurea belongs to Miscellaneous; Idecabtagene vicleucel belongs to Oncology.
Why it happens
Cytotoxic and myelosuppressive effects may impair T-cell collection and expansion and add immunosuppression.
What to do
Stop hydroxyurea before leukapheresis and lymphodepletion, following the product labeling and treating team's guidance. Monitor for infection and cytopenias.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Hydroxyurea and Idecabtagene vicleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Hydroxyurea
Other interactions of Idecabtagene vicleucel
Frequently asked questions
Can I take Hydroxyurea with Idecabtagene vicleucel?
MediHelp rates the interaction as major. Hydroxyurea and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Hydroxyurea is myelosuppressive and may impair T-cell collection and CAR-T expansion. It may also add to infection risk after infusion.
How serious is the interaction between Hydroxyurea and Idecabtagene vicleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop hydroxyurea before leukapheresis and lymphodepletion, following the product labeling and treating team's guidance. Monitor for infection and cytopenias.
What other medicines interact with Hydroxyurea?
MediHelp also lists interactions of Hydroxyurea with, for example, Didanosine, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel. The full list is on the Hydroxyurea page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
